We are live on ! Find out more
DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Delisted

DRNA was delisted on the 27th of December, 2021.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$16.8M -$883K -252,005 -8%
RCM
2
RA Capital Management
Massachusetts
$14.3M
RI
3
RTW Investments
New York
$11.9M
A
4
Abingworth
United Kingdom
$5.56M
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.87M -$155K -44,185 -8%
EAM
6
Eventide Asset Management
Massachusetts
$2.22M
6CM
7
683 Capital Management
New York
$2.06M +$1.23M +350,000 New
BFA
8
BlackRock Fund Advisors
California
$1.97M +$66.2K +18,881 +6%
Renaissance Technologies
9
Renaissance Technologies
New York
$1.91M +$871K +248,400 +329%
PAI
10
Palo Alto Investors
California
$1.57M
UBS Group
11
UBS Group
Switzerland
$1.56M +$909K +259,400 +4,069%
OFM
12
Omega Fund Management
Massachusetts
$1.31M
TAM
13
Tiverton Asset Management
Delaware
$758K -$1.12M -319,032 -71%
DCM
14
DAFNA Capital Management
California
$701K
BCM
15
Bridgeway Capital Management
Texas
$549K +$327K +93,300 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$501K +$259 +74 +0.1%
BIT
17
BlackRock Institutional Trust
California
$473K
OAM
18
Oxford Asset Management
United Kingdom
$347K -$797K -227,407 -79%
Jacobs Levy Equity Management
19
Jacobs Levy Equity Management
New Jersey
$328K -$136K -38,700 -41%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$308K -$78.7K -22,451 -30%
SM
21
Sabby Management
Florida
$294K +$175K +50,000 New
ACA
22
Avoro Capital Advisors
New York
$271K +$162K +46,082 New
Millennium Management
23
Millennium Management
New York
$261K -$29.3K -8,371 -16%
Northern Trust
24
Northern Trust
Illinois
$257K +$25.1K +7,149 +20%
Goldman Sachs
25
Goldman Sachs
New York
$254K -$1.15K -328 -0.8%